PGC-1α levels on the 1st and 7th days of life and at 36 weeks PMA were higher in the mild and non-BPD groups than in the moderate/severe BPD group (P < 0.05). This evidence concerns the gene PPARGC1A and bronchopulmonary dysplasia.